Genetic syndromes are prevalent in patients with comorbid neurodevelopmental disorders and catatonia
- 29 August 2023
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (11) , 2716-2722
Abstract
Catatonia occurs at high rates in idiopathic and syndromic neurodevelopmental disorders. At our institution's multidisciplinary catatonia clinic, clinical genetic testing (including microarray, fragile X PCR and methylation, autism/ID expanded panels, and exome sequencing) was commonly completed as part of clinical workup on patients with co‐occurring neurodevelopmental disorders and catatonia (performed in 36/48 cases or 75%). This testing identified a pathogenic or likely pathogenic finding in 15/36 patients (42%). Testing identified a VUS (variant of uncertain significance) in 9/36 patients (25%). On review of the VUS findings, 4/9 were felt to be suspicious and potentially diagnostic. Testing was negative for 12/36 patients (33%). Many of the variants identified in this cohort were found in genes involved in gamma aminobutyric acid (GABA) and glutamatergic synaptic signaling; imbalances of these neurotransmitters are hypothesized to be drivers of catatonia. More work is needed to further characterize the molecular underpinnings of catatonia in the setting of neurodevelopmental disorders, including expanding genetic testing to larger cohorts in the future.Keywords
This publication has 17 references indexed in Scilit:
- DYRK1A and cognition: A lifelong relationshipPharmacology & Therapeutics, 2019
- CADD: predicting the deleteriousness of variants throughout the human genomeNucleic Acids Research, 2018
- Catatonia in Children and Adolescents: A High Rate of Genetic ConditionsJournal of the American Academy of Child & Adolescent Psychiatry, 2018
- X-linked ichthyosis associated with psychosis and behavioral abnormalities: a case reportJournal of Medical Case Reports, 2017
- Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesityAmerican Journal of Medical Genetics Part A, 2016
- Diagnostic and Statistical Manual of Mental Disorders2013
- 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disordersJournal of Human Genetics, 2011
- Identification and functional characterization of rare mutations of the neuroligin-2 gene ( NLGN2 ) associated with schizophreniaHuman Molecular Genetics, 2011
- Progressive Neurodegeneration in Patients with Primary Immunodeficiency Disease on IVIG TreatmentClinical Immunology, 2002
- Schizophrenia susceptibility gene locus at Xp22.3Clinical Genetics, 1999